Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,191
archived clinical trials in
Constipation

Mechanism of Action of Biofeedback Therapy
Mechanism of Action of Biofeedback Therapy
Status: Enrolling
Updated:  9/16/2014
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Mechanism of Action of Biofeedback Therapy
Mechanism of Action of Biofeedback Therapy
Status: Enrolling
Updated: 9/16/2014
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Study to Evaluate the Effects of RM-131 in Patients With Chronic Constipation
A Single-center, Placebo-controlled, Double-blind, Study to Evaluate the Effects of RM-131 on Colonic Motor Functions in Patients With Chronic Constipation
Status: Enrolling
Updated:  10/23/2014
Mayo Clinic Rochester
mi
from
Rochester, MN
Study to Evaluate the Effects of RM-131 in Patients With Chronic Constipation
A Single-center, Placebo-controlled, Double-blind, Study to Evaluate the Effects of RM-131 on Colonic Motor Functions in Patients With Chronic Constipation
Status: Enrolling
Updated: 10/23/2014
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Ogden, UT
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Ogden, UT
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Phoenix, AR
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Phoenix, AR
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Artesia, CA
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Artesia, CA
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Orange, CA
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Riverside, CA
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Riverside, CA
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
San Diego, CA
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Hialeah, FL
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Miami, FL
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Miami Lakes, FL
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Crowley, LA
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Crowley, LA
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Monroe, LA
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Monroe, LA
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Boston, MA
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Chesterfield, MI
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Chesterfield, MI
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
St. Louis, MO
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Brooklyn, NY
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Brooklyn, NY
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Great Neck, NY
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Great Neck, NY
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Raleigh, NC
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Mentor, OH
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Mentor, OH
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Chattanooga, TN
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Cincinnati, TN
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Cincinnati, TN
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Smyrna, TN
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Smyrna, TN
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Houston, TX
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
San Antonio, TX
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Webster, TX
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Webster, TX
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Lynchburg, VA
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Lynchburg, VA
Click here to add this to my saved trials
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Huntsville, AL
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
Elobixibat Colonic Motor Function Study
A Single Center, Placebo-controlled Trial to Evaluate the Effects of Elobixibat in Colonic Motor Functions in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  3/13/2015
Mayo Clinic Rochester
mi
from
Rochester, MN
Elobixibat Colonic Motor Function Study
A Single Center, Placebo-controlled Trial to Evaluate the Effects of Elobixibat in Colonic Motor Functions in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 3/13/2015
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Use of Novel Prebiotic Fiber for Targeted Dietary Management of Irritable Bowel Syndrome (Nutrabiotix Phase II)
Use of Novel Prebiotic Fiber for Targeted Dietary Management of Irritable Bowel Syndrome (Nutrabiotix Phase II)
Status: Enrolling
Updated:  4/1/2015
Rush University Medical Center
mi
from
Chicago, IL
Use of Novel Prebiotic Fiber for Targeted Dietary Management of Irritable Bowel Syndrome (Nutrabiotix Phase II)
Use of Novel Prebiotic Fiber for Targeted Dietary Management of Irritable Bowel Syndrome (Nutrabiotix Phase II)
Status: Enrolling
Updated: 4/1/2015
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Methylnaltrexone Use for Opioid-induced Postoperative Constipation
The Use of Methylnaltrexone to Reduce Post-operative Opioid-induced Constipation in the Pediatric Spinal Fusion Patient
Status: Enrolling
Updated:  5/15/2015
Shriners Hospitals for Children- Spokane
mi
from
Spokane, WA
Methylnaltrexone Use for Opioid-induced Postoperative Constipation
The Use of Methylnaltrexone to Reduce Post-operative Opioid-induced Constipation in the Pediatric Spinal Fusion Patient
Status: Enrolling
Updated: 5/15/2015
Shriners Hospitals for Children- Spokane
mi
from
Spokane, WA
Click here to add this to my saved trials
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated:  7/7/2015
Alliance Clinical Research
mi
from
Birmingham, AL
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated: 7/7/2015
Alliance Clinical Research
mi
from
Birmingham, AL
Click here to add this to my saved trials
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated:  7/7/2015
Horizon Research Group, Inc.
mi
from
Mobile, AL
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated: 7/7/2015
Horizon Research Group, Inc.
mi
from
Mobile, AL
Click here to add this to my saved trials
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated:  7/7/2015
HOPE Research Institute
mi
from
Phoenix, AZ
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated: 7/7/2015
HOPE Research Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated:  7/7/2015
Advanced Rx Clinical Research
mi
from
Artelia, CA
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated: 7/7/2015
Advanced Rx Clinical Research
mi
from
Artelia, CA
Click here to add this to my saved trials
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated:  7/7/2015
TriWest Research Associates, LLC
mi
from
El Cajon, CA
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated: 7/7/2015
TriWest Research Associates, LLC
mi
from
El Cajon, CA
Click here to add this to my saved trials
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated:  7/7/2015
Akkiance Research Centers
mi
from
Laguna Hills, CA
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated: 7/7/2015
Akkiance Research Centers
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated:  7/7/2015
Primecare Clinical Research
mi
from
Lajuna Hills, CA
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated: 7/7/2015
Primecare Clinical Research
mi
from
Lajuna Hills, CA
Click here to add this to my saved trials
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated:  7/7/2015
Samaritan Center for Medical Research
mi
from
Los Gatos, CA
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated: 7/7/2015
Samaritan Center for Medical Research
mi
from
Los Gatos, CA
Click here to add this to my saved trials
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated:  7/7/2015
Precision Research Institute, LLC
mi
from
San Diego, CA
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated: 7/7/2015
Precision Research Institute, LLC
mi
from
San Diego, CA
Click here to add this to my saved trials
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated:  7/7/2015
Southeast Clinical Research, Llc
mi
from
Jacksonville, FL
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated: 7/7/2015
Southeast Clinical Research, Llc
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated:  7/7/2015
Physician Care Clinical Research, LLC
mi
from
Sarasota, FL
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated: 7/7/2015
Physician Care Clinical Research, LLC
mi
from
Sarasota, FL
Click here to add this to my saved trials
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated:  7/7/2015
Soth Miami Clinical Research
mi
from
South Miami, FL
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated: 7/7/2015
Soth Miami Clinical Research
mi
from
South Miami, FL
Click here to add this to my saved trials
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated:  7/7/2015
Chicago Anesthesia Pain Specialists
mi
from
Chicago, IL
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated: 7/7/2015
Chicago Anesthesia Pain Specialists
mi
from
Chicago, IL
Click here to add this to my saved trials
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated:  7/7/2015
ActivMed Practices & Research
mi
from
Newington, NH
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated: 7/7/2015
ActivMed Practices & Research
mi
from
Newington, NH
Click here to add this to my saved trials
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated:  7/7/2015
Atco Medical Associates, P.C.
mi
from
Atco, NJ
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated: 7/7/2015
Atco Medical Associates, P.C.
mi
from
Atco, NJ
Click here to add this to my saved trials
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated:  7/7/2015
DiGiovanna Institute for Medical Education and Research
mi
from
North Massapequa, NY
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated: 7/7/2015
DiGiovanna Institute for Medical Education and Research
mi
from
North Massapequa, NY
Click here to add this to my saved trials
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated:  7/7/2015
Gaffnew Health Services
mi
from
Charlotte, NC
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated: 7/7/2015
Gaffnew Health Services
mi
from
Charlotte, NC
Click here to add this to my saved trials
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated:  7/7/2015
Clinical Inquest Center Ltd.
mi
from
Beavercreek, OH
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated: 7/7/2015
Clinical Inquest Center Ltd.
mi
from
Beavercreek, OH
Click here to add this to my saved trials
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated:  7/7/2015
Ohio Clinical Research Partners, LLC
mi
from
Canton, OH
Longitudinal Study of Patients With Opioid-Induced Constipation
Longitudinal Study of Patients With Opioid-Induced Constipation
Status: Enrolling
Updated: 7/7/2015
Ohio Clinical Research Partners, LLC
mi
from
Canton, OH
Click here to add this to my saved trials